• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

骨扫描中转移灶的鉴别诊断:化疗所致骨坏死。

Differential diagnosis of metastases in bone scans: chemotherapy induced bone necrosis.

作者信息

Reuland P, Kaiserling E, Klingebiel T, Feine U, Niethammer D

机构信息

Abt. Nuklearmedizin, Eberhard-Karls-Universität Tübingen, Deutschland.

出版信息

Nuklearmedizin. 1999;38(2):38-42.

PMID:10100229
Abstract

AIM

Influenced by the incorrect diagnosis of a bone metastasis caused by bone necrosis we evaluated reasons and frequency of bone necrosis in patients referred for bone scanning in follow-up of tumors.

METHODS

Bone scans performed within two years on patients with primary bone tumors or tumors metastatic to bone were reviewed in respect to the final diagnosis bone necrosis.

RESULTS

We found the cases of three young patients who presented the appearance of hot spots on bone scintigrams which were finally diagnosed as bone necrosis. In two cases the diagnosis was based on histological findings, in one case the diagnosis was made evident by follow-up. All the three patients had been treated by chemotherapy and presented no other reason for the development of bone necrosis. Enhanced tracer uptake in all sites decreased within eight weeks up to two years without therapy.

CONCLUSION

Single and multiple hot spots after chemotherapy may be originated by bone necrosis but mimicry metastases.

摘要

目的

受骨坏死导致骨转移误诊的影响,我们评估了在肿瘤随访中接受骨扫描的患者发生骨坏死的原因及频率。

方法

回顾了原发性骨肿瘤或骨转移瘤患者在两年内进行的骨扫描,以确定最终诊断为骨坏死的情况。

结果

我们发现3例年轻患者的骨闪烁显像出现热点表现,最终诊断为骨坏死。2例诊断基于组织学检查结果,1例通过随访确诊。所有3例患者均接受过化疗,且无其他导致骨坏死的原因。未经治疗的情况下,所有部位增强的示踪剂摄取在8周内至两年内均下降。

结论

化疗后出现的单个或多个热点可能源于骨坏死,但会模仿转移瘤。

相似文献

1
Differential diagnosis of metastases in bone scans: chemotherapy induced bone necrosis.骨扫描中转移灶的鉴别诊断:化疗所致骨坏死。
Nuklearmedizin. 1999;38(2):38-42.
2
Thallium-201 scanning for the evaluation of osteosarcoma and soft-tissue sarcoma. A study of the evaluation and predictability of the histological response to chemotherapy.铊-201扫描用于骨肉瘤和软组织肉瘤的评估。一项关于化疗组织学反应评估及可预测性的研究。
J Bone Joint Surg Am. 1993 Apr;75(4):526-31. doi: 10.2106/00004623-199304000-00008.
3
Occult trauma mimicking metastases on bone scans in pediatric oncology patients.儿科肿瘤患者骨扫描中酷似转移瘤的隐匿性创伤。
Pediatr Radiol. 1997 Feb;27(2):114-8. doi: 10.1007/s002470050080.
4
Response of osteosarcoma and Ewing sarcoma to preoperative chemotherapy: assessment with dynamic and static MR imaging and skeletal scintigraphy.骨肉瘤和尤文肉瘤对术前化疗的反应:采用动态和静态磁共振成像及骨闪烁显像进行评估
Invest Radiol. 1992 Nov;27(11):989-91.
5
Evaluation of chemotherapy response in primary bone tumors with F-18 FDG positron emission tomography compared with histologically assessed tumor necrosis.用F-18 FDG正电子发射断层扫描评估原发性骨肿瘤的化疗反应,并与组织学评估的肿瘤坏死情况进行比较。
Clin Nucl Med. 2000 Nov;25(11):874-81. doi: 10.1097/00003072-200011000-00004.
6
Late effects of chemotherapy and radiotherapy in osteosarcoma and Ewing sarcoma patients: the Italian Sarcoma Group Experience (1983-2006).骨肉瘤和尤文肉瘤患者化疗和放疗的晚期效应:意大利肉瘤研究组经验(1983-2006)。
Cancer. 2012 Oct 15;118(20):5050-9. doi: 10.1002/cncr.27493. Epub 2012 Mar 13.
7
Response of osteosarcoma and Ewing sarcoma to chemotherapy: imaging evaluation.骨肉瘤和尤文肉瘤对化疗的反应:影像学评估
AJR Am J Roentgenol. 1991 Oct;157(4):825-33. doi: 10.2214/ajr.157.4.1892044.
8
Bone scanning in Ewing's sarcoma.尤因肉瘤的骨扫描
J Nucl Med. 1985 Apr;26(4):349-52.
9
[Preliminary report of combination chemotherapy including Arsenic trioxide for stage III osteosarcoma and Ewing sarcoma].[含三氧化二砷的联合化疗用于Ⅲ期骨肉瘤和尤因肉瘤的初步报告]
Zhonghua Wai Ke Za Zhi. 2006 Jun 15;44(12):805-8.
10
Bone mineral density deficits in pediatric patients treated for sarcoma.接受肉瘤治疗的儿科患者的骨矿物质密度不足。
Pediatr Blood Cancer. 2008 May;50(5):1032-8. doi: 10.1002/pbc.21281.